AVITA Medical Inc.

NASDAQ: RCEL · Real-Time Price · USD
5.80
0.04 (0.69%)
At close: Aug 14, 2025, 3:59 PM
5.88
1.38%
After-hours: Aug 14, 2025, 04:28 PM EDT

AVITA Medical Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
64.25M 50.14M 50.56M 33.02M
Cost of Revenue
9.09M 7.78M 8.87M 6.1M
Gross Profit
55.16M 42.36M 41.69M 26.92M
Operating Income
-56.59M -42.66M -40.4M -25.12M
Interest Income
n/a n/a 23.5K n/a
Pretax Income
-61.79M -35.31M -39.12M -25.1M
Net Income
-61.84M -35.38M -39.17M -25.14M
Selling & General & Admin
91.39M 65.63M 66.46M 37.92M
Research & Development
20.36M 20.82M 20.35M 15.67M
Other Expenses
n/a -1.43M n/a -1.55M
Operating Expenses
111.75M 85.02M 80.78M 52.04M
Interest Expense
5.36M 1.14M n/a n/a
Selling & Marketing Expenses
58.2M 37.29M 32.19M 16.27M
Cost & Expenses
120.84M 92.8M 89.65M 58.14M
Income Tax Expense
54K 66K 52.88K 42K
Shares Outstanding (Basic)
25.88M 25.33M 25M 24.36M
Shares Outstanding (Diluted)
25.88M 25.33M 25M 24.36M
EPS (Basic)
-2.39 -1.4 -1.57 -1.03
EPS (Diluted)
-2.39 -1.4 -1.57 -1.03
EBITDA
-55.34M -32.45M -39.57M -24.4M
EBIT
-56.43M -34.17M n/a -25.08M
Depreciation & Amortization
1.13M 632K 1.46M 673K